{"transactions":[{"id":793583,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:28:53.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001380177-26-000004","document":"wk-form4_1777930129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017726000004/wk-form4_1777930129.xml","form_type":"4"}},{"id":793582,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:53.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":123761,"source":{"system":"sec-edgar","filing":"0001380177-26-000004","document":"wk-form4_1777930129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017726000004/wk-form4_1777930129.xml","form_type":"4"}},{"id":975720,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":false,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, as compensation for Board and Committee service. The shares underlying the options exercised were fully vested on May 22, 2025."}],"balance_after":0,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975719,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":14884,"price":11.8978,"value":177086.8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97."}],"balance_after":98417,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975718,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":10864,"price":11.8978,"value":129257.6992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock sold solely to satisfy the option exercise price and applicable taxes associated with the option exercise."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $11.88 to $11.97."}],"balance_after":113301,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975717,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"exercise","planned":false,"acquired":true,"shares":25748,"price":5.02,"value":129254.96,"ownership":{"direct":true},"balance_after":124165,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":975716,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T23:01:01.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":7100,"price":12.1113,"value":85990.23,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12."}],"balance_after":98417,"source":{"system":"sec-edgar","filing":"0001380177-25-000006","document":"wk-form4_1765321258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000138017725000006/wk-form4_1765321258.xml","form_type":"4"}},{"id":1160826,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:43.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000111","document":"wk-form4_1746232297.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000111/wk-form4_1746232297.xml","form_type":"4"}},{"id":1160825,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:43.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":105517,"source":{"system":"sec-edgar","filing":"0001367644-25-000111","document":"wk-form4_1746232297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000111/wk-form4_1746232297.xml","form_type":"4"}},{"id":1500055,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:14:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000076","document":"wk-form4_1716945249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000076/wk-form4_1716945249.xml","form_type":"4"}},{"id":1500054,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:14:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":71114,"source":{"system":"sec-edgar","filing":"0001367644-24-000076","document":"wk-form4_1716945249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000076/wk-form4_1716945249.xml","form_type":"4"}},{"id":1874423,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T23:06:21.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":53684,"source":{"system":"sec-edgar","filing":"0001367644-23-000106","document":"wk-form4_1685487966.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000106/wk-form4_1685487966.xml","form_type":"4"}},{"id":2102256,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-29T20:26:05.000Z","date":"2022-11-25","kind":"sale","acquired":false,"shares":1912,"price":11.94,"value":22829.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":19837,"source":{"system":"sec-edgar","filing":"0001367644-22-000148","document":"wf-form4_166975354620077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000148/wf-form4_166975354620077.xml","form_type":"4"}},{"id":2250989,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:17:15.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":21749,"source":{"system":"sec-edgar","filing":"0001367644-22-000090","document":"wf-form4_165402821355835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000090/wf-form4_165402821355835.xml","form_type":"4"}},{"id":2698370,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:05:51.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":5027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":13303,"source":{"system":"sec-edgar","filing":"0001367644-21-000091","document":"wf-form4_162189033525294.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000091/wf-form4_162189033525294.xml","form_type":"4"}},{"id":3061553,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T20:46:46.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":6297,"price":131,"value":824907.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to a computational error in the Form 4 filed on February 25, 2020, Mr. Richard's subsequently filed From 4s showed the incorrect amount of securities beneficially owned. The amount of securities beneficially owned has been corrected herein."}],"balance_after":8276,"source":{"system":"sec-edgar","filing":"0001367644-20-000130","document":"wf-form4_159717877286677.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000130/wf-form4_159717877286677.xml","form_type":"4"}},{"id":3119968,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-05T20:36:36.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":6572,"price":87.514,"value":575142.008,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $87.51 to $87.58."}],"balance_after":4269,"source":{"system":"sec-edgar","filing":"0001367644-20-000102","document":"wf-form4_159138937855980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000102/wf-form4_159138937855980.xml","form_type":"4"}},{"id":3134813,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T13:13:08.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":2821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":10841,"source":{"system":"sec-edgar","filing":"0001367644-20-000078","document":"wf-form4_159049877040558.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000078/wf-form4_159049877040558.xml","form_type":"4"}},{"id":3159206,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T21:08:40.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":8375,"price":80.1945,"value":671628.9375,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0000 to $80.8660, inclusive."}],"balance_after":8020,"source":{"system":"sec-edgar","filing":"0001367644-20-000051","document":"wf-form4_158879930355638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000051/wf-form4_158879930355638.xml","form_type":"4"}},{"id":3167218,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-04-29T20:35:52.000Z","date":"2020-04-27","kind":"exercise","acquired":false,"shares":7893,"price":78,"value":615654.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of options granted under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":20.08,"expiration_date":"2021-05-19","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001367644-20-000041","document":"wf-form4_158819253519592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000041/wf-form4_158819253519592.xml","form_type":"4"}},{"id":3167217,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T20:35:52.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":7893,"price":78,"value":615654.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":16395,"source":{"system":"sec-edgar","filing":"0001367644-20-000041","document":"wf-form4_158819253519592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000041/wf-form4_158819253519592.xml","form_type":"4"}},{"id":3167216,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T20:35:52.000Z","date":"2020-04-27","kind":"exercise","acquired":true,"shares":7893,"price":20.08,"value":158491.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":24288,"source":{"system":"sec-edgar","filing":"0001367644-20-000041","document":"wf-form4_158819253519592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000041/wf-form4_158819253519592.xml","form_type":"4"}},{"id":3248608,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-25T21:30:42.000Z","date":"2020-02-21","kind":"exercise","acquired":false,"shares":5152,"price":18.64,"value":96033.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date."}],"balance_after":7893,"derivative":{"exercise_price":18.64,"exercise_date":"2017-05-21","expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":5152},"source":{"system":"sec-edgar","filing":"0001367644-20-000013","document":"wf-form4_158266622472686.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000013/wf-form4_158266622472686.xml","form_type":"4"}},{"id":3248607,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T21:30:42.000Z","date":"2020-02-21","kind":"sale","acquired":false,"shares":5152,"price":65,"value":334880.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":16395,"source":{"system":"sec-edgar","filing":"0001367644-20-000013","document":"wf-form4_158266622472686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000013/wf-form4_158266622472686.xml","form_type":"4"}},{"id":3248606,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T21:30:42.000Z","date":"2020-02-21","kind":"exercise","acquired":true,"shares":5152,"price":18.64,"value":96033.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":31851,"source":{"system":"sec-edgar","filing":"0001367644-20-000013","document":"wf-form4_158266622472686.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000013/wf-form4_158266622472686.xml","form_type":"4"}},{"id":3374114,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2019-11-12T14:51:22.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":5153,"price":18.64,"value":96051.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. The date herein represents the third anniversary date of the grant and the final vesting date."}],"balance_after":5152,"derivative":{"exercise_price":18.64,"exercise_date":"2017-05-21","expiration_date":"2021-05-21","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001367644-19-000060","document":"wf-form4_157357026669636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764419000060/wf-form4_157357026669636.xml","form_type":"4"}},{"id":3374113,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T14:51:22.000Z","date":"2019-11-07","kind":"sale","acquired":false,"shares":5153,"price":60,"value":309180.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":26699,"source":{"system":"sec-edgar","filing":"0001367644-19-000060","document":"wf-form4_157357026669636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764419000060/wf-form4_157357026669636.xml","form_type":"4"}},{"id":3374112,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T14:51:22.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":5153,"price":18.64,"value":96051.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":31852,"source":{"system":"sec-edgar","filing":"0001367644-19-000060","document":"wf-form4_157357026669636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764419000060/wf-form4_157357026669636.xml","form_type":"4"}},{"id":3509955,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T00:11:28.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":5736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":26699,"source":{"system":"sec-edgar","filing":"0001567619-19-012275","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919012275/doc1.xml","form_type":"4"}},{"id":3770384,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-08T22:14:11.000Z","date":"2018-11-07","kind":"exercise","acquired":false,"shares":7893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":13,"expiration_date":"2020-05-22","underlying":"Comon Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001567619-18-005447","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005447/doc1.xml","form_type":"4"}},{"id":3770383,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T22:14:11.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":7893,"price":70,"value":552510.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":20963,"source":{"system":"sec-edgar","filing":"0001567619-18-005447","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005447/doc1.xml","form_type":"4"}},{"id":3770382,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T22:14:11.000Z","date":"2018-11-07","kind":"exercise","acquired":true,"shares":7893,"price":13,"value":102609.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":28856,"source":{"system":"sec-edgar","filing":"0001567619-18-005447","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918005447/doc1.xml","form_type":"4"}},{"id":3834647,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Bury)","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-21","kind":"exercise","acquired":false,"shares":7793,"price":14.71,"value":114635.03,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":14.71,"expiration_date":"2020-05-19","underlying":"Common Stock","underlying_shares":7793},"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3834646,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-03","kind":"exercise","acquired":false,"shares":100,"price":14.71,"value":1471.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":7793,"derivative":{"exercise_price":14.71,"expiration_date":"2020-05-19","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3834645,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-21","kind":"sale","acquired":false,"shares":7793,"price":60.0166,"value":467709.3638,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to 60.05, inclusive."}],"balance_after":20963,"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3834644,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-21","kind":"exercise","acquired":true,"shares":7793,"price":14.71,"value":114635.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":28756,"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3834643,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-03","kind":"sale","acquired":false,"shares":100,"price":60,"value":6000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":20963,"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3834642,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-23T12:51:52.000Z","date":"2018-08-03","kind":"exercise","acquired":true,"shares":100,"price":14.71,"value":1471.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":21063,"source":{"system":"sec-edgar","filing":"0001567619-18-001687","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918001687/doc1.xml","form_type":"4"}},{"id":3901281,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T20:21:37.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":7342,"price":53,"value":389126.0,"ownership":{"direct":true},"balance_after":20963,"source":{"system":"sec-edgar","filing":"0001140361-18-027686","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118027686/doc1.xml","form_type":"4"}},{"id":3918266,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T22:28:40.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the day prior to the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":28305,"source":{"system":"sec-edgar","filing":"0001140361-18-025559","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118025559/doc1.xml","form_type":"4"}},{"id":3959942,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-19T20:49:15.000Z","date":"2018-04-17","kind":"exercise","acquired":false,"shares":7893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant is fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.37,"expiration_date":"2019-05-16","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001140361-18-019061","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118019061/doc1.xml","form_type":"4"}},{"id":3959941,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T20:49:15.000Z","date":"2018-04-17","kind":"sale","acquired":false,"shares":7893,"price":55,"value":434115.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001140361-18-019061","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118019061/doc1.xml","form_type":"4"}},{"id":3959940,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T20:49:15.000Z","date":"2018-04-17","kind":"exercise","acquired":true,"shares":7893,"price":13.37,"value":105529.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":31303,"source":{"system":"sec-edgar","filing":"0001140361-18-019061","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118019061/doc1.xml","form_type":"4"}},{"id":4133010,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-12-13T13:20:51.000Z","date":"2017-12-12","kind":"exercise","acquired":false,"shares":23681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.64,"expiration_date":"2019-05-21","underlying":"Common Stock","underlying_shares":23681},"source":{"system":"sec-edgar","filing":"0001140361-17-045941","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117045941/doc1.xml","form_type":"4"}},{"id":4133009,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T13:20:51.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":23681,"price":45.0245,"value":1066225.1845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.17, inclusive."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001140361-17-045941","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117045941/doc1.xml","form_type":"4"}},{"id":4133008,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T13:20:51.000Z","date":"2017-12-12","kind":"exercise","acquired":true,"shares":23681,"price":10.64,"value":251965.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":47091,"source":{"system":"sec-edgar","filing":"0001140361-17-045941","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117045941/doc1.xml","form_type":"4"}},{"id":4199005,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-28","kind":"exercise","acquired":false,"shares":22415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.99,"expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":22415},"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4199004,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-27","kind":"exercise","acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":22415,"derivative":{"exercise_price":7.99,"expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4199003,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-28","kind":"sale","acquired":false,"shares":22415,"price":40,"value":896600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4199002,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-28","kind":"exercise","acquired":true,"shares":22415,"price":7.99,"value":179095.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":45825,"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4199001,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-27","kind":"sale","acquired":false,"shares":1266,"price":40,"value":50640.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4199000,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-29T23:04:49.000Z","date":"2017-09-27","kind":"exercise","acquired":true,"shares":1266,"price":7.99,"value":10115.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard."}],"balance_after":24676,"source":{"system":"sec-edgar","filing":"0001140361-17-037011","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117037011/doc1.xml","form_type":"4"}},{"id":4302642,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy) (Common Stock)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."}],"balance_after":10305,"derivative":{"exercise_price":18.64,"exercise_date":"2017-05-22","expiration_date":"2021-05-22","underlying":"Common Stock","underlying_shares":10305},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302641,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy) (Common Stock)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":7893,"derivative":{"exercise_price":13,"expiration_date":"2020-05-23","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302640,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy) (Common Stock)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":7893,"derivative":{"exercise_price":13.37,"expiration_date":"2019-05-17","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302639,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":7893,"derivative":{"exercise_price":20.08,"expiration_date":"2021-05-19","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302638,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":7893,"derivative":{"exercise_price":14.71,"expiration_date":"2020-05-20","underlying":"Common Stock","underlying_shares":7893},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302637,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":23681,"derivative":{"exercise_price":10.64,"expiration_date":"2019-05-21","underlying":"Common Stock","underlying_shares":23681},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302636,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-05-26T17:44:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":2081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant.  The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant is fully vested."}],"balance_after":23681,"derivative":{"exercise_price":7.99,"expiration_date":"2018-05-21","underlying":"Common Stock","underlying_shares":23681},"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4302635,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T17:44:16.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001140361-17-022467","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117022467/doc1.xml","form_type":"4"}},{"id":4520294,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T01:48:23.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":100,"price":34.06,"value":3406.0,"ownership":{"direct":true},"balance_after":15151,"source":{"system":"sec-edgar","filing":"0001140361-16-089899","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036116089899/doc1.xml","form_type":"4"}},{"id":4520293,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T01:48:23.000Z","date":"2016-12-13","kind":"sale","acquired":false,"shares":5800,"price":34.0863,"value":197700.54,"ownership":{"direct":true},"balance_after":15251,"source":{"system":"sec-edgar","filing":"0001140361-16-089899","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036116089899/doc1.xml","form_type":"4"}},{"id":4520292,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T01:48:23.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"In connection with the spin-off (the \"Spin-off\") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. (\"Emergent\"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019."}],"balance_after":21051,"source":{"system":"sec-edgar","filing":"0001140361-16-089899","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036116089899/doc1.xml","form_type":"4"}},{"id":4520291,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T01:48:23.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the spin-off (the \"Spin-off\") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. (\"Emergent\"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017 and May 2018."}],"balance_after":20474,"source":{"system":"sec-edgar","filing":"0001140361-16-089899","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036116089899/doc1.xml","form_type":"4"}},{"id":4520290,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49917,"kind":"person","name":"Richard Ronald","position":1,"cik":"0001380177","reported_name":"Richard Ronald","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-16T01:48:23.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the spin-off (the \"Spin-off\") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. (\"Emergent\"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017."}],"balance_after":19870,"source":{"system":"sec-edgar","filing":"0001140361-16-089899","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036116089899/doc1.xml","form_type":"4"}}]}